Stock analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Down 21.0 %
NASDAQ RKDA opened at $4.64 on Friday. The firm has a 50-day moving average price of $4.68 and a 200 day moving average price of $3.60. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The stock has a market capitalization of $6.33 million, a P/E ratio of -1.08 and a beta of 0.90.
About Arcadia Biosciences
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- What is a Secondary Public Offering? What Investors Need to Know
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is a Special Dividend?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Using the MarketBeat Stock Split Calculator
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.